Research Involving Human Subjects

This site provides, HHS and NIH requirements and resources for the extramural community involved in human subjects research in their roles as: Applicants/Grantees, Offerors/Contractors, Peer Reviewers, Institutional Officials. 

News Flash:

OHRP Notice Requesting Public Comment on Appropriateness of FDA's Draft Guidance Document on Electronic Informed Consent in Clinical Investigations for Research Regulated under 45 CFR part 46

On March 9, 2015, the Food and Drug Administration (FDA) announced in the Federal Register (FR) the availability of a draft guidance for industry, clinical investigators, and institutional review boards entitled "Use of Electronic Informed Consent in Clinical Investigations: Questions and Answers." The guidance provides recommendations for clinical investigators, sponsors, and institutional review boards on the use of electronic media and processes to obtain informed consent for FDA-regulated clinical investigations of medical products, including human drug and biological products, medical devices and combinations thereof. The Office for Human Research Protections (OHRP) in the same issue of the FR, published a notice requesting public comment on whether FDA's draft guidance document would be appropriate for all research regulated under 45 CFR part 46.

 

The OHRP and FDA have been actively working to harmonize the agencies' regulatory requirements and guidance for human subject research, and the FDA draft guidance document was developed as a part of these efforts. Although this document is issued by FDA and is drafted as guidance that would apply to FDA-regulated clinical investigations, OHRP is considering whether to adopt the positions and recommendations proposed in this guidance for research regulated under the HHS protection of human subjects regulations, 45 CFR part 46, and to issue a joint OHRP and FDA guidance document on this topic when the final guidance document is developed.

OHRP's FR Notice with instructions on how to submit comments to OHRP can be accessed at: http://www.gpo.gov/fdsys/pkg/FR-2015-03-09/pdf/2015-05301.pdf. Comments are due by May 7, 2015.

FDA's FR Notice with instructions on how to submit comments to FDA can be accessed at: http://www.gpo.gov/fdsys/pkg/FR-2015-03-09/pdf/2015-05377.pdf. Comments are due by May 8, 2015.

FDA's Draft Guidance document can be accessed at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM436811.pdf.


 

Regulations, Policies & Guidance
Research with Vulnerable Populations
Research Using Human Specimens, Cell Lines, or Data
   
Human Subjects Protections Training
NIH Inclusion Policies and Procedures
Frequently Asked Questions
Additional Resources
For questions or comments regarding this site, contact Human Subjects Mailbox.